OrbiMed’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,935,200	Closed	-$18.7M	–	175
2020 Q4	$18.7M	Hold	1,935,200	–	–	0.16%	104
2020 Q3	$17.4M	Hold	1,935,200	–	–	0.22%	90
2020 Q2	$23.9M	Buy	+1,935,200	New	+$23.9M	0.34%	70
2019 Q2	–	Sell	-4,079,000	Closed	-$64M	–	128
2019 Q1	$64M	Buy	+4,079,000	New	+$64M	0.99%	32
2018 Q2	–	Hold	0	–	–	–	143
2018 Q1	–	Hold	0	–	–	–	138
2017 Q4	–	Sell	-405,500	Closed	-$7.14M	–	137
2017 Q3	$7.14M	Sell	405,500 -120,800	-23%	-$2.13M	0.07%	112
2017 Q2	$17.5M	Buy	526,300 +113,700	+28%	+$3.78M	0.18%	84
2017 Q1	$13.2M	Sell	412,600 -201,900	-33%	-$6.48M	0.15%	87
2016 Q4	$22.3M	Sell	614,500 -1,216,900	-66%	-$44.1M	0.28%	66
2016 Q3	$84.3M	Sell	1,831,400 -928,400	-34%	-$42.7M	0.96%	40
2016 Q2	$139M	Buy	2,759,800 +63,800	+2%	+$3.2M	1.45%	22
2016 Q1	$144M	Buy	2,696,000 +250,000	+10%	+$13.4M	1.52%	21
2015 Q4	$161M	Buy	2,446,000 +247,000	+11%	+$16.2M	1.45%	23
2015 Q3	$124M	Buy	2,199,000 +1,892,000	+616%	+$107M	1.25%	25
2015 Q2	$18.1M	Sell	307,000 -784,000	-72%	-$46.3M	0.15%	84
2015 Q1	$68M	Buy	1,091,000 +691,000	+173%	+$43M	0.58%	47
2014 Q4	$23M	Sell	400,000 -262,000	-40%	-$15.1M	0.22%	68
2014 Q3	$35.6M	Buy	+662,000	New	+$35.6M	0.37%	51
2014 Q2	–	Hold	0	–	–	–	127
2014 Q1	–	Hold	0	–	–	–	129
2013 Q4	–	Hold	0	–	–	–	123
2013 Q3	–	Hold	0	–	–	–	114